글로벌 담낭암 치료 시장 – 2030년까지의 산업 동향 및 예측

담낭암 치료 시장 분석 및 규모

증가하는 의료비 지출과 진보적이고 혁신적인 진단 및 치료 방법의 도입도 글로벌 담낭암 치료 시장 성장을 견인할 수 있습니다. 긍정적인 결과를 보여주는 존경받는 비율과 전반적인 생존율의 증가는 글로벌 담낭암 치료 시장 성장의 기회로 작용할 수 있습니다. 완전한 외과적 종양 절제는 담낭암에 대한 유일한 치료법이지만, 간문과 같은 중요한 구조가 존재하고 암이 간 영역으로 침윤할 가능성이 있기 때문에 절제는 어려운 과제 중 하나입니다.

Data Bridge Market Research는 2022년에 7,950만 달러였던 글로벌 담낭암 치료 시장이 2030년까지 1억 2,140만 달러에 도달할 것으로 예상되며, 2023-2030년 예측 기간 동안 6.50%의 CAGR을 보일 것으로 분석했습니다. 이는 시장 가치를 나타냅니다. "간 기능 검사"는 전 세계적으로 담낭암 유병률이 증가함에 따라 글로벌 담낭암 치료 시장의 진단 부문을 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

담낭암 치료 시장 범위 및 세분화

Market Definition

Gallbladder is an organ which is situated under the lungs and is small and pear-shaped organ. The overgrowth of cancer or malignant cells in the tissues of the gallbladder leads to gallbladder cancer. The type of cancer is rare and mainly affects the female population. Different symptoms of gallbladder cancer are pain (above stomach), jaundice, lumps in the abdomen and fever. The gallbladder cancer is very difficult to detect in the early stage as there is absence of signs and if signs are there, it represents the other illnesses. For the treatment of cancer, different methods such as chemotherapy, immunotherapy, surgery and many other methods are done according to the patient’s adaptability and stage of the cancer. Drugs which are used for the treatment are gemzar, platinol, 5-fluorouracil, xeloda, and eloxatin. Immunotherapy drugs used for the treatment of cancer are nivolumab (opdivo) and pembrolizumab (keytruda). According to American Cancer Society, only 1 out of 5 gallbladder cancers are detected at early stage.            

Global Gallbladder Cancer Treatment Market Dynamics

Drivers

• Increasing Incidence of Gallbladder Cancer

A significant driver is the rising incidence of gallbladder cancer, particularly in regions where it is more prevalent, such as South Asia and South America. This drives the demand for diagnostic and treatment options.

• Advancements in Medical Technology

Advances in medical technology, including improved diagnostic methods (such as imaging and biomarker detection) and minimally invasive surgical techniques, have enhanced the ability to diagnose and treat gallbladder cancer effectively.

• Growing Awareness and Early Detection

Increased awareness of gallbladder cancer risk factors, such as obesity and gallstones, has led to more individuals seeking regular check-ups and early detection. Early diagnosis often leads to better treatment outcomes

• Growing Investment in Research and Development

Investment in research and development by pharmaceutical and biotechnology companies has led to the development of new drugs and therapies for gallbladder cancer treatment. These innovations can expand treatment options and improve patient outcomes.

Opportunities

• Emerging Markets

Growing healthcare infrastructure and increasing medical tourism in emerging markets present significant growth opportunities for gallbladder cancer treatment manufacturers.

• Advances in Genomics and Precision Medicine

Advances in genomics and precision medicine offer an opportunity to tailor treatments based on the genetic profile of individual patients. Developing targeted therapies for specific genetic mutations associated with gallbladder cancer can improve treatment efficacy and reduce side effects.

Restraints/ Challenges

• High Cost of Treatment

Cancer treatment, including surgery, chemotherapy, and radiation therapy, can be expensive. High treatment costs can be a barrier to access for some patients, particularly in regions with limited healthcare resources.

• Limited Treatment Options

Compared to some other types of cancer, there are relatively fewer treatment options available for gallbladder cancer. Surgery remains the primary treatment, and there is a need for more effective adjuvant therapies, such as chemotherapy and radiation therapy.

• Competitive Market

Early diagnosis is crucial for improving gallbladder cancer outcomes, but reliable early detection methods are limited. Most cases are diagnosed at advanced stages when treatment options are more limited. Developing effective screening and early detection methods remains a significant challenge.

• Limited Early Detection Methods

Ensuring that healthcare professionals are well-trained in electrosurgery techniques is crucial to prevent complications. Addressing the shortage of skilled operators can be challenging.

This global gallbladder cancer treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global gallbladder cancer treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In December 2022, India-based startup PredOmix launched a one-of-its-kind innovative cancer detection blood test, OncoVeryx-F, capable of detecting early-stage cancers in women with a 98% accuracy
• In June 2022, Roche launched the new BenchMark ULTRA PLUS system for cancer diagnostics enabling timely, targeted patient care

Global Gallbladder cancer treatment Market Scope

Global gallbladder cancer treatment market is segmented on the basis of indication type, treatment type, diagnosis, route of administration and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Indication Type

• Stage I
• Stage II
• Stage III
• Stage IV

Treatment Type

• Surgery
• Cholecystectomy
• Radical Gallbladder Resection
• Palliative Surgery
• Radiation therapy
• Chemotherapy
• Monotherapy
• Combination Therapy
• Immunotherapy

Diagnosis

• Physical Examination
• Liver function Test
• Blood Test
• CT Scan
• Ultrasound
• Percutaneous Transhepatic Cholangiography (PTC)
• Endoscopic Retrograde Cholangiopancreatography (ERC)
• Magnetic Resonance Imaging (MRI)
• Endoscopic Ultrasound (EUS)
• Laparoscopy
• Biopsy

Route of Administration

• Oral
• Injections

End Users

• Hospitals
• Gynaecology Clinics
• Academic and Research Centers

Global Gallbladder cancer treatment Market Analysis/Insights

The global gallbladder cancer treatment market is analysed and market size insights and trends are provided by country, indication type, treatment type, diagnosis, route of administration and end users as referenced above.

The countries covered in the global gallbladder cancer treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America dominates the global gallbladder cancer treatment market due to high adoption rate of advanced technology and the presence of skilled professionals within the region.  

Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period of 2023 to 2030 owing to the growing foreign direct investments, increase in disposable incomes and rising awareness about advanced and minimally invasive surgical techniques in patients.

글로벌 담낭암 치료 시장 보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 소비량, 생산 현장 및 양, 수입 수출 분석, 가격 추세 분석, 원자재 비용, 하류 및 상류 가치 사슬 분석과 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다. 글로벌 담낭암 치료 시장을 분석하고 시장 규모 통찰력과 트렌드를 제공합니다.

경쟁 환경 및 글로벌 담낭암 치료 시장 점유율 분석

글로벌 담낭암 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 담낭암 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 담낭암 치료 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 메드트로닉(미국)
• B. 브라운 멜순겐(독일)
• 존슨앤존슨 프라이빗 리미티드(미국)
• 스미스+네퓨(영국)
• Symmetry Surgical Inc. (미국)
• CONMED Corporation(미국)
• Erbe Elektromedizin GmbH(독일)
• 올림푸스 주식회사(일본)
• 보스턴 사이언티픽 코퍼레이션(미국)
• Cipla Inc. (인도)
• 브리스톨-마이어스 스퀴브 회사(미국)
• 엘리 릴리 앤드 컴퍼니(미국)
• 파이저 주식회사(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• 사노피(프랑스)
• OncoTherapy Science, Inc. (일본)
• 인튜이티브서지컬(미국)
• Samarth Pharma Pvt. Ltd.(인도)
• Sun Pharmaceutical Industries Ltd. (인도)

SKU-60048